Accelerating innovation for Alzheimer’s disease and other dementias is a key challenge. Over the past few years, the OECD has conducted work in a number of areas related to innovation in biomedical research and health innovation for healthy ageing. The workshop aimed to provide an international forum for all stakeholders to drive forward a change in the global paradigm in biomedical research and health innovation for Alzheimer’s disease and other dementias. Discussions at the workshop have shown that progress on key issues is being made, thanks to a willingness of stakeholders to join forces and work together towards a future cure. In line with recommendations of the G8 Dementia Summit Declaration to strengthen collaboration for innovation and cross-sector partnerships this report considers the challenges and options to promote and accelerate research in dementia and its transformation into innovative therapies and diagnostics.
Enhancing Translational Research and Clinical Development for Alzheimer's Disease and other Dementias
Policy paper
Share
Facebook
Twitter
LinkedIn
Abstract
In the same series
-
21 May 202645 Pages -
Policy paper
Trends and priorities, 2019‑2023
20 May 202648 Pages -
4 December 202563 Pages
-
1 December 202537 Pages
-
Policy paper
A case study within the OECD’s Global Green Iron project
22 October 202564 Pages
Related publications
-
Policy paper5 September 202546 Pages
-
Policy brief5 September 20255 Pages
-
Working paper14 November 202342 Pages
-
5 July 202356 Pages
-
Working paper
Findings from the NESTI 2022 pilot data collection
13 June 202351 Pages -
9 February 202357 Pages